| CYSB1900198 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products | Supplementary Application | 2019-05-22 | 上海复宏汉霖生物制药有限公司 | Shanghai Henlius Biopharmaceutical Co Ltd | Certificate Issued | 2020-04-15 | view |
| CXSS1700026 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products(2) | New Drug Application | 2017-12-11 | 上海复宏汉霖生物制药有限公司 | Shanghai Henlius Biopharmaceutical Co Ltd;Shanghai Henlius Biotech Co Ltd | Certificate Issued | 2019-03-04 | view |
| CYSB2100027 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products | Supplementary Application | 2021-01-15 | 上海复宏汉霖生物制药有限公司 | Shanghai Henlius Biopharmaceutical Co Ltd | Certificate Issued | 2021-09-14 | view |
| CYSB1900197 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products | Supplementary Application | 2019-05-22 | 上海复宏汉霖生物制药有限公司 | Shanghai Henlius Biopharmaceutical Co Ltd | Certificate Issued | 2020-04-23 | view |
| CYSB2000107 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products | Supplementary Application | 2020-05-23 | 上海复宏汉霖生物制药有限公司 | Shanghai Henlius Biopharmaceutical Co Ltd | Certificate Issued | 2020-07-16 | view |
| CYSB2000106 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products | Supplementary Application | 2020-05-23 | 上海复宏汉霖生物制药有限公司 | Shanghai Henlius Biopharmaceutical Co Ltd | Certificate Issued | 2020-07-16 | view |
| CXSS2000059 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products(2.2) | New Drug Application | 2020-12-24 | 上海复宏汉霖生物制药有限公司 | Shanghai Henlius Biopharmaceutical Co Ltd | In Review | 2020-12-23 | view |
| CYSB2000306 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(原2) | Supplementary Application | 2020-11-25 | 上海复宏汉霖生物制药有限公司 | Shanghai Henlius Biopharmaceutical Co Ltd | In Review | 2022-01-27 | view |
| CXSB2000101 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(原2) | Supplementary Application | 2020-11-24 | 上海复宏汉霖生物制药有限公司 | Shanghai Henlius Biopharmaceutical Co Ltd | In Review | 2020-11-23 | view |
| CYSB2000229 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(原2) | Supplementary Application | 2020-10-17 | 上海复宏汉霖生物制药有限公司 | Shanghai Henlius Biopharmaceutical Co Ltd | In Review | 2020-10-16 | view |
| CXSS1900021 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(2) | New Drug Application | 2019-04-29 | 上海复宏汉霖生物制药有限公司 | Shanghai Henlius Biopharmaceutical Co Ltd;Shanghai Henlius Biotech Co Ltd | Certificate Issued | 2020-08-19 | view |
| CYSB2000307 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(原2) | Supplementary Application | 2020-11-25 | 上海复宏汉霖生物制药有限公司 | Shanghai Henlius Biopharmaceutical Co Ltd | Certificate Issued | 2021-02-05 | view |
| CYSB2000228 | 注射用曲妥珠单抗 | trastuzumab | Lyophilized | Biological Products(原2) | Supplementary Application | 2020-10-17 | 上海复宏汉霖生物制药有限公司 | Shanghai Henlius Biopharmaceutical Co Ltd | In Review | 2020-10-16 | view |
| CXSS2000047 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(3.3) | New Drug Application | 2020-09-09 | 上海复宏汉霖生物制药有限公司 | Shanghai Henlius Biopharmaceutical Co Ltd | Certificate Issued | 2021-12-07 | view |
| CXSL2000004 | 重组抗CTLA-4全人单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2020-01-15 | 上海复宏汉霖生物制药有限公司 | Shanghai Henlius Biopharmaceutical Co Ltd | In Review | 2020-01-14 | view |
| CXSB2100008 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products(1) | Supplementary Application | 2021-01-29 | 上海复宏汉霖生物技术股份有限公司；上海复宏汉霖生物制药有限公司 | Shanghai Henlius Biopharmaceutical Co Ltd;Shanghai Henlius Biotech Co Ltd | In Review | 2021-01-28 | view |
| CYSB2100026 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(原2) | Supplementary Application | 2021-01-15 | 上海复宏汉霖生物制药有限公司 | Shanghai Henlius Biopharmaceutical Co Ltd | In Review | 2022-01-19 | view |
| CXSS1900001 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2019-01-28 | 上海复宏汉霖生物制药有限公司 | Shanghai Henlius Biopharmaceutical Co Ltd;Shanghai Henlius Biotech Co Ltd | Certificate Issued | 2020-12-10 | view |
